Compare moats

The 20-F describes a migration market made of SAP's own customers: RISE with SAP 'is targeted at our installed base customers and helps them on their journey from legacy ERP systems to SAP Business Suite' — an installed base so entrenched that moving WITHIN the vendor is a multi-year journey, with the Q2 2026 statement showing €22.9 billion of contractually committed cloud backlog, up 27%.

source: sec.gov

MACOM’s FY2025 10-K describes advantages that are real but contested. On the durable side: a catalog of “thousands of standard and custom devices” serving “over 6,000 end customers”; its own compound-semiconductor fabs (GaAs, GaN and InP) in Lowell, Research Triangle Park, Ann Arbor and Limeil-Brévannes; a Lowell fab accredited by the U.S. Department of Defense with “Trusted Foundry” status, in markets where “a domestic fabrication facility may be a requirement to be a strategic supplier”; and product life cycles of five to ten years, “with some of our products generating revenue for over 20 years”. On the limiting side, the same filing calls its markets “highly competitive”, names ADI, Broadcom, Credo, Marvell, MaxLinear, Microchip, NXP, Qorvo, Semtech, Skyworks and Sumitomo among its significant competitors, “some of whom have greater financial resources and scale than us”, adds “increased competition from Chinese companies”, sells “primarily on a purchase order basis” with no minimum purchase commitments, and warns that “the ASPs of our products may decrease over time”. Its income statement reports gross profit of $385,797 thousand on revenue of $648,407 thousand in fiscal 2023, $393,773 thousand on $729,578 thousand in fiscal 2024 and $529,002 thousand on $967,258 thousand in fiscal 2025. Process know-how and defense accreditation that larger rivals can contest, product generation by product generation, is a narrow moat rather than a wide one.

source: sec.gov

Axcelis's FY2025 10-K describes a protected but contested position. On the durable side, it says 'Axcelis and Applied Materials are the only ion implant system manufacturers with a full range of implant products'. About 3,400 Axcelis products are in use in 27 countries, and they feed an aftermarket business (CS&I) that earned $268.0 million, or 31.9% of 2025 revenue. The company holds 169 active U.S. patents and 356 active patents granted in other countries. On the limiting side, the risk factors say the ion implant segment 'includes one company with substantially greater financial, engineering, manufacturing, marketing and customer service and support resources', as well as 'several smaller companies that could provide innovative systems'. U.S. export controls 'exacerbate the risk that Chinese customers will change suppliers to non-U.S. vendors', while Kingstone Semiconductor and CETC 'continue to develop ion implanters for the Chinese domestic market'. 'None of our customers have entered into a long-term agreement requiring it to purchase our products.' Revenue fell to $839.0 million in 2025 from $1,017.9 million in 2024. A full-line position with a large installed base, against a better-resourced rival and new Chinese entrants, is a narrow moat.

source: sec.gov

ERP is the system of record for a company's core processes; the 20-F's own strategy language — SAP Business Suite as 'the destination for all our customers,' with AI-enabled migration tools easing the journey off SAP's own legacy systems — is a switching-cost moat described from the inside.

source: sec.gov

The FY2025 10-K places the advantage in process and design know-how: “We continue to invest in proprietary processes, circuit design and packaging technologies”, “we utilize a broad array of internal, proprietary process technologies and commercially available foundry technologies”, and U.S.-based wafer fabrication “enables us to offer proprietary processes” and provides “a domestic source for U.S. I&D customers”. The filing itself says patents matter less than people: MACOM held 729 U.S. and 497 foreign issued patents as of October 3, 2025, but “we believe that our future success will be determined by the innovation, technical expertise and management abilities of our engineers and management more than by patent ownership”. Switching costs are the weaker candidate: long product life cycles help in Industrial & Defense, but sales are made on purchase orders and new business must be won through “a competitive selection process to develop semiconductors for use in our customers' systems, known in the industry as a ‘design win.’”

source: sec.gov

The FY2025 10-K grounds the advantage in owned implant technology rather than contractual lock-in. Its Purion implanters share 'a common platform which enables a unique combination of implant purity, precision, and productivity', and its high energy systems use 'production-proven RF Linac high energy, spot beam technology'. System assembly and testing stays in-house 'due to the high degree of expertise and intellectual property associated with the process and design'. The company holds 169 active U.S. and 356 foreign patents, though it says it is not 'substantially dependent on any single patent or any group of patents'. The installed base supports aftermarket revenue but does not lock customers in: the risk factors say customers often train 'their own staff to maintain and service' equipment and buy parts that are not patent-protected from third parties. Switching costs are therefore the weaker candidate.

source: sec.gov

Grounded in scale and position rather than an asserted share: the 20-F describes a market segment consisting of SAP's own legacy estates (RISE), and the Q2 statement shows Cloud ERP Suite revenue of €5.5 billion in a single quarter, up 25% — no competitor filing this site tracks describes an installed-base market of its own.

source: sec.gov

The only independent ranking found is for the optical analog line. Deep Fundamental’s “Deep Dive: Optical Module Market” of September 27, 2024 (https://deepfundamental.substack.com/p/deep-dive-optical-module-market) states “In the driver/TIA market, Marvell ($MRVL) and Macom ($MTSI) are the dominant players, especially in the high-end 400G+ segment” and “in the LPO market, Macom holds a significant advantage, largely because Marvell, strong in DSP, tends to promote solutions that include DSP”. That is a shared front rank, from an equity-research newsletter rather than a market tracker, and now two years old. MACOM’s own FY2025 10-K claims no rank - it says “We believe that we compete favorably” - and names significant competitors from ADI and Broadcom to Marvell and Sumitomo, “some of whom have greater financial resources and scale than us”. No third-party ranking was found for the Industrial & Defense or Telecom lines. A two-year-old newsletter covering one of three segments cannot carry a company-wide co-leader call, so the band is fast follower.

source: sec.gov

The FY2025 10-K says 'In the market for ion implantation systems, we mainly compete against Applied Materials' and that the two 'are the only ion implant system manufacturers with a full range of implant products'. It claims Axcelis 'has been a market leader in high energy ion implanters for many years' and is 'a technology leader and supplier of choice' in power devices. But its risk factors say the implant segment includes 'one company with substantially greater' resources (unnamed there; Applied Materials is the main rival it names), and it lists 'Achieve market share leadership across all served markets' as a 2026 goal rather than a current fact. No third-party market-share source was fetched, so these are the company's own claims. Which of the two full-line suppliers has the larger overall share is not established by the sources read. Because the only basis for a shared lead is the company's own description, and that description treats share leadership as a goal not yet met, the band is held at fast_follower rather than co_leader.

source: sec.gov

Q2 2026: total revenue up 9% with non-IFRS operating profit up 7% — profit growing slightly behind revenue, and the 2026 profit outlook 'updated to reflect dilutive impact from Dremio and Prior Labs acquisitions' rather than raised.

source: sec.gov

The FY2025 10-K says “the ASPs of our products may decrease over time, and we must introduce new products that can be manufactured at lower costs or that command higher prices based on superior performance to offset price erosion”. On inflation it says MACOM has “generally been able to offset increases in these costs through various productivity and cost reduction initiatives, as well as adjusting our selling prices to pass through some of these higher costs to our customers; however, our ability to raise or maintain our selling prices depends on market conditions and competitive dynamics.” Margins have risen with the Data Center mix: the fiscal Q3 2026 earnings release (https://www.sec.gov/Archives/edgar/data/0001493594/000149359426000036/ex99_1earningsreleaseq3fy26.htm) reports GAAP gross margin of 58.3%, compared to 55.3% a year earlier, and guides fiscal Q4 adjusted gross margin to between 60.0% and 61.0%. The release does not say how much of that is price rather than mix or fab utilisation.

source: sec.gov

The FY2025 10-K reports gross margin of 44.9% in 2025 against 44.7% in 2024. That held steady while revenue fell from $1,017.9 million to $839.0 million, but its risk factors warn that 'if we must lower prices to remain competitive without commensurate cost of goods savings, our gross margin and profitability will be adversely affected'. They also say that if suppliers raise component costs, Axcelis 'may not be able to raise the price of our products to cover all or part of the increased cost'. On the Q2 2026 call (https://www.marketbeat.com/earnings/reports/2026-8-5-axcelis-technologies-inc-stock/), management reported a non-GAAP gross margin of 42.7% (the call states its income-statement measures are non-GAAP unless noted, so it is not directly comparable with the 10-K's GAAP figures), 'slightly below our outlook of 43%', citing CS&I mix and higher than anticipated services costs.

source: sec.gov

Layer-10 application incumbent embedding AI (Joule, Business AI) into the enterprise system of record.

MACOM sells components that customers build into larger systems - the FY2025 10-K lists wireless basestations, high-capacity optical networks, data center networks, radar, medical systems, satellite networks and test and measurement. In the AI chain it sits upstream of optical-module makers, supplying TIAs, drivers, lasers and photodetectors for 800G and 1.6T transceivers. Sales to distributors were 32.3% of fiscal 2025 revenue, two resellers took 12.4% and 11.2%, and no direct customer reached 10%.

A front-end wafer-fab equipment supplier to chipmakers, concentrated in Asia and in power devices. The FY2025 10-K says implanter shipments to Asian customers were 76.0% of 2025 system revenue, international sales 83.7% of total revenue, and the top ten customers 55.2% of net sales. It also says sales to Chinese customers are expected to remain significant under U.S. export-control licensing.

• Business AI (Joule, Joule Agents, Business Data Cloud) Unknown · Moderate source: sec.gov
• Cloud ERP Suite (S/4HANA Cloud, BTP, LoB solutions) Leader · Deep source: sec.gov
• On-premise software support Unknown · Deep source: sec.gov

• Optical TIAs and modulator/laser drivers Top 3 · Moderate source: deepfundamental.substack.com
• Photodetectors and lasers for optical transceivers Unknown · Moderate source: marketbeat.com
• RF, microwave and GaN products for Industrial & Defense Unknown · Moderate source: sec.gov
• Telecom optical and RF components Unknown · Moderate source: sec.gov

• CS&I aftermarket (spares, upgrades, used tools, services) Unknown · Moderate source: sec.gov
• High current and medium current implanters (Purion H, Dragon, H200, Purion M) Unknown · Moderate source: sec.gov
• High energy implanters (Purion XE/EXE, GSD Ovation batch) Top 3 · Moderate source: sec.gov
• Power device implanters (Purion Power Series) Top 3 · Moderate source: sec.gov

Editorial prior, not backtested.

see exactly how it voted →

Editorial prior, not backtested.

see exactly how it voted →

Editorial prior, not backtested.

see exactly how it voted →